The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib
CompletedOBSERVATIONAL
Enrollment
59
Participants
Timeline
Start Date
March 15, 2015
Primary Completion Date
March 31, 2020
Study Completion Date
May 31, 2020
Conditions
Non Small Cell Lung CancerEGF-R Positive Non-Small Cell Lung CancerEGFR Gene Mutation
Interventions
DRUG
Afatinib
Treatment with Afatinib, any line, in metastatic, EGFR mutated patients with NSCLC
All Listed Sponsors
lead
Hellenic Cooperative Oncology Group
OTHER
NCT04640870 - The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib | Biotech Hunter | Biotech Hunter